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Video-assisted Thoracoscopic Surgery for Diaphragmatic
Defect Complication With Refractory Hydrothorax
Related to Radiofrequency Ablation
Mong-Wei Lin, Jang-Ming Lee*
Hepatocellular carcinoma (HCC) is the fifth most
common cancer in the world.1 Partial hepatectomy
is considered to be the mainstay therapy for HCC.
However, surgical resection still has limitations in
the treatment of HCC, especially in patients with
poor liver function reserve and those with wide-
spread intrahepatic recurrence. Several non-surgical
therapies have been developed, including radiofre-
quency ablation (RFA) and percutaneous ethanol
injection. Here we report an uncommon compli-
cation of refractory hydrothorax following RFA.
The patient was successfully treated with video-
assisted thoracoscopic surgery (VATS).
A 47-year-old men was referred to our hospital
from another hospital after 3 months of refractory
hydrothorax. He had received four local acetic acid
injections and one RFA in the preceding 2 years
for HCC. He received a second RFA for recurrent
liver tumors 3 months prior to the current con-
sultation. Right hepatic hydrothorax developed
shortly thereafter, with transudative pleural effu-
sion that showed no malignant cells or positive
culture results. Sputum studies were also negative
for malignancy. After repeated sessions of thora-
cocentesis, pleural effusion persisted (Figure A).
Chest computed tomography showed radiofre-
quency-ablated liver tumors near the diaphragm
(Figure B) without pleural or lung lesions. The
patient underwent VATS for diagnosis and further
management. Two 1-mm diaphragmatic defects
were noted near the reflection of the diaphragm
(Figures C and D). Diaphragmatic tissue near the
defect was fibrotic due to injury stemming from
RFA. The defects were closed using a primary pro-
lene suture and the patient was discharged with
no further hydrothorax. No respiratory symptoms
or hydrothorax were reported during the 1-year
follow-up period.
RFA has attracted great interest due to its 
effectiveness and safety for small or unresected
HCC.2−5 RFA is performed through a needle elec-
trode inserted into the liver tumor under ultra-
sonic or computed tomographic guidance. The
radiofrequency energy causes ionic agitation and
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frictional heat, which leads to coagulative necro-
sis of tumor cells.2 Among the two most popular
non-surgical therapies, RFA showed a significant
smaller risk of local recurrence and better sur-
vival than percutaneous ethanol injection.3−5
However, the overall rate of complications was
higher with RFA.5 The major complication rate
was 4.1–4.8% and the overall complication rate
was 19%.4,5
A potential complication of RFA is heat dam-
age of the peripheral organs. Diaphragm damage
is rare, but still may occur, especially with periph-
eral liver tumors that are adjacent to the diaphragm
refraction area. A persistent diaphragm defect,
caused by RFA, may lead to refractory hydrotho-
rax. The differential diagnoses of hydrothorax in
HCC patients who undergo RFA include malig-
nant pleural effusion, infectious pleural effusion,
and diaphragm injury-related pleural effusion. If
thoracocentesis and pleural effusion studies do
not lead to a diagnosis, VATS is helpful in both
diagnosis and management of refractory hydro-
thorax. Our diagnosis was finally confirmed by
means of VATS and the defect was repaired 
simultaneously and successfully.
To the best of our knowledge, this is the first
reported case of refractory hydrothorax related to
RFA treated with VATS. Although the complication
is uncommon, it should be regarded as a differen-
tial diagnosis, especially when the tumor is near
the diaphragm.
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Figure. (A) CXR demonstrated hydrothorax in the right lower chest field. (B) The radiofrequency ablated liver tumors were
near the diaphragm (arrow). No pleura or lung lesion was noted. (C, D) The diaphragmatic defects were noted near the
diaphragm reflection (arrow). The diaphragmatic tissue near the defect was fibrotic due to injury from RFA.
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